Literature DB >> 29276286

Biosimilar Substitution Laws.

Michael Gabay1.   

Abstract

Keywords:  drug information; education; legal aspects; pharmacists

Year:  2017        PMID： 29276286      PMCID： PMC5735730          DOI： 10.1177/0018578717726995

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  1 in total

Review 1.  Biosimilars: Rationale and current regulatory landscape.

Authors:  Ewa Olech
Journal:  Semin Arthritis Rheum       Date:  2016-01-21       Impact factor: 5.532
  1 in total
  3 in total

1.  Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review.

Authors:  Hanna M Tolonen; Jenni Falck; Pekka Kurki; Päivi Ruokoniemi; Katri Hämeen-Anttila; Kenneth M Shermock; Marja Airaksinen
Journal:  BioDrugs       Date:  2021-08-16       Impact factor: 5.807

Review 2.  Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice.

Authors:  Kelley D Mayden; John M Kelton; Joanne C Ryan; Ali McBride
Journal:  J Adv Pract Oncol       Date:  2022-06-21

3.  Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions.

Authors:  Chana A Sacks; Victor L Van de Wiele; Lisa A Fulchino; Lajja Patel; Aaron S Kesselheim; Ameet Sarpatwari
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.